AI’s regulatory battle lines form
Politico January 3, 2024
Neither Congress nor the Biden administration has moved yet to set new rules for the use of advanced artificial intelligence in health care.
Even so, big regulatory questions are coming to the fore.
Rep. Greg Murphy, a North Carolina Republican who co-chairs the GOP Doctors Caucus, favors rules that are “narrow in scope,” protect physicians who use the technology from liability and avoid “overlapping regulatory governance” that would make it more difficult for patients to gain access to emerging therapies.
Murphy spelled out his thinking in a letter today to Food and Drug Administration Commissioner Robert Califf, who figures to be a key player in the development of new rules.
The FDA authorizes some AI products under its existing rules...